nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluorescein—ABCC1—Dactinomycin—peripheral nervous system neoplasm	0.131	0.16	CbGbCtD
Fluorescein—ABCB11—Vincristine—peripheral nervous system neoplasm	0.114	0.139	CbGbCtD
Fluorescein—CYP1A1—Tretinoin—peripheral nervous system neoplasm	0.109	0.133	CbGbCtD
Fluorescein—ABCC1—Epirubicin—peripheral nervous system neoplasm	0.0949	0.116	CbGbCtD
Fluorescein—CYP1A1—Dacarbazine—peripheral nervous system neoplasm	0.0933	0.114	CbGbCtD
Fluorescein—ABCC1—Vincristine—peripheral nervous system neoplasm	0.0807	0.0987	CbGbCtD
Fluorescein—ABCC1—Etoposide—peripheral nervous system neoplasm	0.0739	0.0904	CbGbCtD
Fluorescein—ABCB11—Doxorubicin—peripheral nervous system neoplasm	0.071	0.0868	CbGbCtD
Fluorescein—ABCC1—Doxorubicin—peripheral nervous system neoplasm	0.0504	0.0617	CbGbCtD
Fluorescein—Oedema—Alitretinoin—peripheral nervous system neoplasm	0.000319	0.00174	CcSEcCtD
Fluorescein—Angiopathy—Etoposide—peripheral nervous system neoplasm	0.000318	0.00174	CcSEcCtD
Fluorescein—Immune system disorder—Etoposide—peripheral nervous system neoplasm	0.000316	0.00173	CcSEcCtD
Fluorescein—Eczema—Epirubicin—peripheral nervous system neoplasm	0.000316	0.00173	CcSEcCtD
Fluorescein—Mediastinal disorder—Etoposide—peripheral nervous system neoplasm	0.000315	0.00173	CcSEcCtD
Fluorescein—Chills—Etoposide—peripheral nervous system neoplasm	0.000314	0.00172	CcSEcCtD
Fluorescein—Shock—Alitretinoin—peripheral nervous system neoplasm	0.000313	0.00172	CcSEcCtD
Fluorescein—Nervous system disorder—Alitretinoin—peripheral nervous system neoplasm	0.000312	0.00171	CcSEcCtD
Fluorescein—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.000312	0.00171	CcSEcCtD
Fluorescein—Tremor—Cisplatin—peripheral nervous system neoplasm	0.000312	0.00171	CcSEcCtD
Fluorescein—Tachycardia—Alitretinoin—peripheral nervous system neoplasm	0.000311	0.0017	CcSEcCtD
Fluorescein—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.00031	0.00169	CcSEcCtD
Fluorescein—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.00031	0.00169	CcSEcCtD
Fluorescein—Skin disorder—Alitretinoin—peripheral nervous system neoplasm	0.000309	0.00169	CcSEcCtD
Fluorescein—Ill-defined disorder—Cisplatin—peripheral nervous system neoplasm	0.000309	0.00169	CcSEcCtD
Fluorescein—Hyperhidrosis—Alitretinoin—peripheral nervous system neoplasm	0.000308	0.00169	CcSEcCtD
Fluorescein—Oedema—Vincristine—peripheral nervous system neoplasm	0.000307	0.00168	CcSEcCtD
Fluorescein—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.000307	0.00168	CcSEcCtD
Fluorescein—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.000306	0.00167	CcSEcCtD
Fluorescein—Asthenia—Topotecan—peripheral nervous system neoplasm	0.000304	0.00166	CcSEcCtD
Fluorescein—Hot flush—Epirubicin—peripheral nervous system neoplasm	0.000303	0.00166	CcSEcCtD
Fluorescein—Thrombophlebitis—Doxorubicin—peripheral nervous system neoplasm	0.000303	0.00166	CcSEcCtD
Fluorescein—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.000302	0.00165	CcSEcCtD
Fluorescein—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.000302	0.00165	CcSEcCtD
Fluorescein—Nervous system disorder—Vincristine—peripheral nervous system neoplasm	0.000301	0.00165	CcSEcCtD
Fluorescein—Menopausal symptoms—Epirubicin—peripheral nervous system neoplasm	0.000301	0.00164	CcSEcCtD
Fluorescein—Malaise—Cisplatin—peripheral nervous system neoplasm	0.0003	0.00164	CcSEcCtD
Fluorescein—Pruritus—Topotecan—peripheral nervous system neoplasm	0.0003	0.00164	CcSEcCtD
Fluorescein—Dysgeusia—Etoposide—peripheral nervous system neoplasm	0.000298	0.00163	CcSEcCtD
Fluorescein—Asthenia—Melphalan—peripheral nervous system neoplasm	0.000298	0.00163	CcSEcCtD
Fluorescein—Hypotension—Alitretinoin—peripheral nervous system neoplasm	0.000298	0.00163	CcSEcCtD
Fluorescein—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.000297	0.00163	CcSEcCtD
Fluorescein—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.000297	0.00163	CcSEcCtD
Fluorescein—Hyperhidrosis—Vincristine—peripheral nervous system neoplasm	0.000297	0.00162	CcSEcCtD
Fluorescein—Pain—Dactinomycin—peripheral nervous system neoplasm	0.000294	0.00161	CcSEcCtD
Fluorescein—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000294	0.00161	CcSEcCtD
Fluorescein—Anaphylactoid reaction—Epirubicin—peripheral nervous system neoplasm	0.000293	0.0016	CcSEcCtD
Fluorescein—Eczema—Doxorubicin—peripheral nervous system neoplasm	0.000292	0.0016	CcSEcCtD
Fluorescein—Cerebrovascular accident—Epirubicin—peripheral nervous system neoplasm	0.000289	0.00158	CcSEcCtD
Fluorescein—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.000288	0.00158	CcSEcCtD
Fluorescein—Hypotension—Vincristine—peripheral nervous system neoplasm	0.000287	0.00157	CcSEcCtD
Fluorescein—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.000286	0.00157	CcSEcCtD
Fluorescein—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.000284	0.00155	CcSEcCtD
Fluorescein—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.000283	0.00155	CcSEcCtD
Fluorescein—Ill-defined disorder—Etoposide—peripheral nervous system neoplasm	0.000283	0.00155	CcSEcCtD
Fluorescein—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.000281	0.00154	CcSEcCtD
Fluorescein—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.000281	0.00154	CcSEcCtD
Fluorescein—Hot flush—Doxorubicin—peripheral nervous system neoplasm	0.00028	0.00154	CcSEcCtD
Fluorescein—Dizziness—Topotecan—peripheral nervous system neoplasm	0.00028	0.00153	CcSEcCtD
Fluorescein—Discomfort—Cisplatin—peripheral nervous system neoplasm	0.00028	0.00153	CcSEcCtD
Fluorescein—Menopausal symptoms—Doxorubicin—peripheral nervous system neoplasm	0.000278	0.00152	CcSEcCtD
Fluorescein—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000278	0.00152	CcSEcCtD
Fluorescein—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000278	0.00152	CcSEcCtD
Fluorescein—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.000276	0.00151	CcSEcCtD
Fluorescein—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000275	0.00151	CcSEcCtD
Fluorescein—Malaise—Etoposide—peripheral nervous system neoplasm	0.000275	0.0015	CcSEcCtD
Fluorescein—Pain—Alitretinoin—peripheral nervous system neoplasm	0.000272	0.00149	CcSEcCtD
Fluorescein—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000272	0.00149	CcSEcCtD
Fluorescein—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.000271	0.00149	CcSEcCtD
Fluorescein—Oedema—Cisplatin—peripheral nervous system neoplasm	0.000271	0.00149	CcSEcCtD
Fluorescein—Anaphylactoid reaction—Doxorubicin—peripheral nervous system neoplasm	0.000271	0.00148	CcSEcCtD
Fluorescein—Cardiac arrest—Epirubicin—peripheral nervous system neoplasm	0.00027	0.00148	CcSEcCtD
Fluorescein—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000269	0.00147	CcSEcCtD
Fluorescein—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.000268	0.00147	CcSEcCtD
Fluorescein—Cerebrovascular accident—Doxorubicin—peripheral nervous system neoplasm	0.000268	0.00147	CcSEcCtD
Fluorescein—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000267	0.00146	CcSEcCtD
Fluorescein—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000267	0.00146	CcSEcCtD
Fluorescein—Rash—Topotecan—peripheral nervous system neoplasm	0.000267	0.00146	CcSEcCtD
Fluorescein—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000267	0.00146	CcSEcCtD
Fluorescein—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000266	0.00146	CcSEcCtD
Fluorescein—Cough—Etoposide—peripheral nervous system neoplasm	0.000266	0.00146	CcSEcCtD
Fluorescein—Headache—Topotecan—peripheral nervous system neoplasm	0.000265	0.00145	CcSEcCtD
Fluorescein—Rash—Tretinoin—peripheral nervous system neoplasm	0.000265	0.00145	CcSEcCtD
Fluorescein—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000265	0.00145	CcSEcCtD
Fluorescein—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000265	0.00145	CcSEcCtD
Fluorescein—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000265	0.00145	CcSEcCtD
Fluorescein—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000265	0.00145	CcSEcCtD
Fluorescein—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000265	0.00145	CcSEcCtD
Fluorescein—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000264	0.00144	CcSEcCtD
Fluorescein—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000264	0.00144	CcSEcCtD
Fluorescein—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000264	0.00144	CcSEcCtD
Fluorescein—Headache—Tretinoin—peripheral nervous system neoplasm	0.000263	0.00144	CcSEcCtD
Fluorescein—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000263	0.00144	CcSEcCtD
Fluorescein—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000263	0.00144	CcSEcCtD
Fluorescein—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000262	0.00144	CcSEcCtD
Fluorescein—Pain—Vincristine—peripheral nervous system neoplasm	0.000262	0.00144	CcSEcCtD
Fluorescein—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000262	0.00144	CcSEcCtD
Fluorescein—Rash—Melphalan—peripheral nervous system neoplasm	0.000262	0.00143	CcSEcCtD
Fluorescein—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000261	0.00143	CcSEcCtD
Fluorescein—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.00026	0.00143	CcSEcCtD
Fluorescein—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000259	0.00142	CcSEcCtD
Fluorescein—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000258	0.00141	CcSEcCtD
Fluorescein—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000256	0.0014	CcSEcCtD
Fluorescein—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000254	0.00139	CcSEcCtD
Fluorescein—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000253	0.00139	CcSEcCtD
Fluorescein—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000253	0.00139	CcSEcCtD
Fluorescein—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000252	0.00138	CcSEcCtD
Fluorescein—Nausea—Topotecan—peripheral nervous system neoplasm	0.000252	0.00138	CcSEcCtD
Fluorescein—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000251	0.00137	CcSEcCtD
Fluorescein—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00025	0.00137	CcSEcCtD
Fluorescein—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00025	0.00137	CcSEcCtD
Fluorescein—Cardiac arrest—Doxorubicin—peripheral nervous system neoplasm	0.000249	0.00137	CcSEcCtD
Fluorescein—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000249	0.00136	CcSEcCtD
Fluorescein—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000246	0.00135	CcSEcCtD
Fluorescein—Nausea—Melphalan—peripheral nervous system neoplasm	0.000246	0.00135	CcSEcCtD
Fluorescein—Asthma—Epirubicin—peripheral nervous system neoplasm	0.000245	0.00134	CcSEcCtD
Fluorescein—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000244	0.00133	CcSEcCtD
Fluorescein—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000243	0.00133	CcSEcCtD
Fluorescein—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000243	0.00133	CcSEcCtD
Fluorescein—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000242	0.00132	CcSEcCtD
Fluorescein—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000242	0.00132	CcSEcCtD
Fluorescein—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.00024	0.00132	CcSEcCtD
Fluorescein—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	0.000239	0.00131	CcSEcCtD
Fluorescein—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000235	0.00128	CcSEcCtD
Fluorescein—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000234	0.00128	CcSEcCtD
Fluorescein—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000232	0.00127	CcSEcCtD
Fluorescein—Pain—Cisplatin—peripheral nervous system neoplasm	0.000232	0.00127	CcSEcCtD
Fluorescein—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000229	0.00125	CcSEcCtD
Fluorescein—Asthma—Doxorubicin—peripheral nervous system neoplasm	0.000227	0.00124	CcSEcCtD
Fluorescein—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000226	0.00124	CcSEcCtD
Fluorescein—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000225	0.00123	CcSEcCtD
Fluorescein—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000224	0.00122	CcSEcCtD
Fluorescein—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000223	0.00122	CcSEcCtD
Fluorescein—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000222	0.00121	CcSEcCtD
Fluorescein—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.000221	0.00121	CcSEcCtD
Fluorescein—Asthenia—Vincristine—peripheral nervous system neoplasm	0.00022	0.00121	CcSEcCtD
Fluorescein—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000218	0.0012	CcSEcCtD
Fluorescein—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000217	0.00119	CcSEcCtD
Fluorescein—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000215	0.00117	CcSEcCtD
Fluorescein—Pain—Etoposide—peripheral nervous system neoplasm	0.000213	0.00116	CcSEcCtD
Fluorescein—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000211	0.00115	CcSEcCtD
Fluorescein—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000205	0.00112	CcSEcCtD
Fluorescein—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000204	0.00112	CcSEcCtD
Fluorescein—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000203	0.00111	CcSEcCtD
Fluorescein—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000203	0.00111	CcSEcCtD
Fluorescein—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000203	0.00111	CcSEcCtD
Fluorescein—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000201	0.0011	CcSEcCtD
Fluorescein—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000201	0.0011	CcSEcCtD
Fluorescein—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.0002	0.00109	CcSEcCtD
Fluorescein—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.0002	0.00109	CcSEcCtD
Fluorescein—Headache—Alitretinoin—peripheral nervous system neoplasm	0.0002	0.00109	CcSEcCtD
Fluorescein—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000198	0.00108	CcSEcCtD
Fluorescein—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000197	0.00108	CcSEcCtD
Fluorescein—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000195	0.00107	CcSEcCtD
Fluorescein—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000195	0.00107	CcSEcCtD
Fluorescein—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000195	0.00107	CcSEcCtD
Fluorescein—Rash—Vincristine—peripheral nervous system neoplasm	0.000194	0.00106	CcSEcCtD
Fluorescein—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000193	0.00106	CcSEcCtD
Fluorescein—Headache—Vincristine—peripheral nervous system neoplasm	0.000192	0.00105	CcSEcCtD
Fluorescein—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000189	0.00104	CcSEcCtD
Fluorescein—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.000185	0.00101	CcSEcCtD
Fluorescein—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000183	0.001	CcSEcCtD
Fluorescein—Nausea—Vincristine—peripheral nervous system neoplasm	0.000182	0.000998	CcSEcCtD
Fluorescein—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000182	0.000997	CcSEcCtD
Fluorescein—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000181	0.000989	CcSEcCtD
Fluorescein—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000178	0.000976	CcSEcCtD
Fluorescein—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000178	0.000974	CcSEcCtD
Fluorescein—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000177	0.00097	CcSEcCtD
Fluorescein—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000177	0.000968	CcSEcCtD
Fluorescein—Chills—Epirubicin—peripheral nervous system neoplasm	0.000176	0.000963	CcSEcCtD
Fluorescein—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000176	0.000963	CcSEcCtD
Fluorescein—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000173	0.000944	CcSEcCtD
Fluorescein—Rash—Cisplatin—peripheral nervous system neoplasm	0.000171	0.000937	CcSEcCtD
Fluorescein—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000171	0.000936	CcSEcCtD
Fluorescein—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000171	0.000935	CcSEcCtD
Fluorescein—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000168	0.000922	CcSEcCtD
Fluorescein—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000167	0.000915	CcSEcCtD
Fluorescein—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000165	0.000901	CcSEcCtD
Fluorescein—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000164	0.0009	CcSEcCtD
Fluorescein—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000164	0.000897	CcSEcCtD
Fluorescein—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000164	0.000895	CcSEcCtD
Fluorescein—Chills—Doxorubicin—peripheral nervous system neoplasm	0.000163	0.000891	CcSEcCtD
Fluorescein—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000161	0.000882	CcSEcCtD
Fluorescein—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000158	0.000867	CcSEcCtD
Fluorescein—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000158	0.000865	CcSEcCtD
Fluorescein—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000158	0.000865	CcSEcCtD
Fluorescein—Rash—Etoposide—peripheral nervous system neoplasm	0.000157	0.000858	CcSEcCtD
Fluorescein—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000157	0.000857	CcSEcCtD
Fluorescein—Headache—Etoposide—peripheral nervous system neoplasm	0.000156	0.000853	CcSEcCtD
Fluorescein—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000155	0.000847	CcSEcCtD
Fluorescein—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000154	0.000843	CcSEcCtD
Fluorescein—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000153	0.000838	CcSEcCtD
Fluorescein—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.00015	0.000822	CcSEcCtD
Fluorescein—Cough—Epirubicin—peripheral nervous system neoplasm	0.000149	0.000816	CcSEcCtD
Fluorescein—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000148	0.00081	CcSEcCtD
Fluorescein—Nausea—Etoposide—peripheral nervous system neoplasm	0.000148	0.000808	CcSEcCtD
Fluorescein—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000147	0.000807	CcSEcCtD
Fluorescein—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000147	0.000802	CcSEcCtD
Fluorescein—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000145	0.000796	CcSEcCtD
Fluorescein—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000144	0.00079	CcSEcCtD
Fluorescein—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000144	0.000786	CcSEcCtD
Fluorescein—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000142	0.00078	CcSEcCtD
Fluorescein—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000142	0.000776	CcSEcCtD
Fluorescein—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000139	0.000763	CcSEcCtD
Fluorescein—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000139	0.000763	CcSEcCtD
Fluorescein—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000139	0.00076	CcSEcCtD
Fluorescein—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000138	0.000755	CcSEcCtD
Fluorescein—Shock—Epirubicin—peripheral nervous system neoplasm	0.000137	0.000751	CcSEcCtD
Fluorescein—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000137	0.000749	CcSEcCtD
Fluorescein—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000137	0.000748	CcSEcCtD
Fluorescein—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000136	0.000747	CcSEcCtD
Fluorescein—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000136	0.000745	CcSEcCtD
Fluorescein—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000135	0.000741	CcSEcCtD
Fluorescein—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000135	0.000737	CcSEcCtD
Fluorescein—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000135	0.000736	CcSEcCtD
Fluorescein—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000134	0.000731	CcSEcCtD
Fluorescein—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000133	0.000727	CcSEcCtD
Fluorescein—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.00013	0.000713	CcSEcCtD
Fluorescein—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000129	0.000706	CcSEcCtD
Fluorescein—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000129	0.000706	CcSEcCtD
Fluorescein—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000127	0.000694	CcSEcCtD
Fluorescein—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.000692	CcSEcCtD
Fluorescein—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.000689	CcSEcCtD
Fluorescein—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.000686	CcSEcCtD
Fluorescein—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000125	0.000685	CcSEcCtD
Fluorescein—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.000682	CcSEcCtD
Fluorescein—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000124	0.00068	CcSEcCtD
Fluorescein—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.00066	CcSEcCtD
Fluorescein—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.00012	0.000659	CcSEcCtD
Fluorescein—Pain—Epirubicin—peripheral nervous system neoplasm	0.000119	0.000652	CcSEcCtD
Fluorescein—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000116	0.000634	CcSEcCtD
Fluorescein—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000115	0.000629	CcSEcCtD
Fluorescein—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000115	0.000629	CcSEcCtD
Fluorescein—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000114	0.000624	CcSEcCtD
Fluorescein—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000111	0.000609	CcSEcCtD
Fluorescein—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000111	0.000606	CcSEcCtD
Fluorescein—Pain—Doxorubicin—peripheral nervous system neoplasm	0.00011	0.000604	CcSEcCtD
Fluorescein—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.00011	0.000603	CcSEcCtD
Fluorescein—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000106	0.000582	CcSEcCtD
Fluorescein—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000105	0.000577	CcSEcCtD
Fluorescein—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000103	0.000562	CcSEcCtD
Fluorescein—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000102	0.000561	CcSEcCtD
Fluorescein—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000102	0.000558	CcSEcCtD
Fluorescein—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.0001	0.000547	CcSEcCtD
Fluorescein—Pruritus—Epirubicin—peripheral nervous system neoplasm	9.86e-05	0.00054	CcSEcCtD
Fluorescein—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	9.5e-05	0.00052	CcSEcCtD
Fluorescein—Asthenia—Doxorubicin—peripheral nervous system neoplasm	9.25e-05	0.000506	CcSEcCtD
Fluorescein—Dizziness—Epirubicin—peripheral nervous system neoplasm	9.22e-05	0.000504	CcSEcCtD
Fluorescein—Pruritus—Doxorubicin—peripheral nervous system neoplasm	9.12e-05	0.000499	CcSEcCtD
Fluorescein—Vomiting—Epirubicin—peripheral nervous system neoplasm	8.86e-05	0.000485	CcSEcCtD
Fluorescein—Rash—Epirubicin—peripheral nervous system neoplasm	8.79e-05	0.000481	CcSEcCtD
Fluorescein—Dermatitis—Epirubicin—peripheral nervous system neoplasm	8.78e-05	0.000481	CcSEcCtD
Fluorescein—Headache—Epirubicin—peripheral nervous system neoplasm	8.73e-05	0.000478	CcSEcCtD
Fluorescein—Dizziness—Doxorubicin—peripheral nervous system neoplasm	8.53e-05	0.000467	CcSEcCtD
Fluorescein—Nausea—Epirubicin—peripheral nervous system neoplasm	8.28e-05	0.000453	CcSEcCtD
Fluorescein—Vomiting—Doxorubicin—peripheral nervous system neoplasm	8.2e-05	0.000449	CcSEcCtD
Fluorescein—Rash—Doxorubicin—peripheral nervous system neoplasm	8.13e-05	0.000445	CcSEcCtD
Fluorescein—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	8.12e-05	0.000445	CcSEcCtD
Fluorescein—Headache—Doxorubicin—peripheral nervous system neoplasm	8.08e-05	0.000442	CcSEcCtD
Fluorescein—Nausea—Doxorubicin—peripheral nervous system neoplasm	7.66e-05	0.000419	CcSEcCtD
